June 12, 2026
The Envol Biomedical team is excited to attend BIO International Convention 2026 in San Diego as part of the LNP Alliance, alongside NeoSome Life Sciences, NIS Nanoimaging Services, and Phosphorex.
As one of the industry’s largest gatherings of biotechnology innovators, BIO International provides an ideal opportunity to connect with sponsors, researchers, and technology partners advancing the next generation of therapeutics. Through the LNP Alliance, attendees can explore a unique network of organizations offering complementary expertise across the development lifecycle of lipid nanoparticle (LNP)-enabled therapies and advanced drug delivery programs.
Supporting Complex Programs from Discovery Through IND-Enabling Development
As therapeutic platforms become increasingly sophisticated, sponsors are seeking development partners capable of generating high-quality preclinical data while helping de-risk critical development decisions. Envol continues to expand its capabilities to support these evolving needs.
During BIO International, our team looks forward to discussing how Envol supports clients through a wide range of preclinical research services, including pharmacokinetic and pharmacodynamic studies, toxicology assessments, safety evaluations, imaging services, and specialized non-human primate (NHP) models.
These capabilities have been further strengthened through recent investments in scientific leadership, expanded GLP support, and strategic collaborations designed to help sponsors navigate increasingly complex regulatory and development pathways.
Expanding Expertise in Toxicology and GLP Programs
One of the most significant developments at Envol over the past year has been the continued expansion of our toxicology and GLP capabilities.
With the addition of experienced toxicology leadership and enhanced quality systems, Envol is helping sponsors generate the robust safety data needed to support regulatory submissions and advance programs with confidence. Our team works closely with clients to design studies that align with both scientific objectives and regulatory expectations, providing the flexibility and responsiveness that emerging biotechnology companies often require.
Whether supporting early-stage candidate evaluation or comprehensive IND-enabling programs, Envol remains focused on delivering reliable data, transparent communication, and scientific partnership throughout the process.
Advanced Imaging and Specialized Research Models
BIO attendees will also have an opportunity to learn more about Envol’s growing imaging capabilities, including MRI, PET/CT, ultrasound, X-ray, and DEXA technologies.
These tools allow researchers to gather critical insights throughout the development process while supporting study designs that generate meaningful translational data. Combined with Envol’s specialized surgical expertise and advanced neuroscience capabilities, these imaging platforms continue to create new opportunities for sponsors developing therapies targeting complex diseases and conditions.
Recent collaborations have further demonstrated the value of integrating advanced imaging with innovative preclinical models, helping sponsors gain a deeper understanding of therapeutic performance before entering clinical development.
The Value of the LNP Alliance
The LNP Alliance was established to bring together organizations with complementary expertise across formulation, characterization, imaging, and preclinical development. By working collaboratively, Alliance members help sponsors access a broader range of capabilities while maintaining the scientific depth needed to advance complex therapeutic programs.
For companies developing lipid nanoparticle-based therapeutics, gene therapies, RNA-based medicines, and other advanced modalities, the Alliance provides access to a network of specialists capable of addressing challenges at multiple stages of development.
Envol’s role within the Alliance centers on generating the preclinical data necessary to evaluate safety, efficacy, biodistribution, and translational potential, helping sponsors move promising therapies closer to the clinic.
Let’s Connect in San Diego
If you’ll be attending BIO International 2026, we invite you to stop by the LNP Alliance exhibit space to meet the Envol Biomedical team and learn more about how our expanding capabilities can support your development goals.
The LNP Alliance will also be hosting an exclusive networking event during the conference. Attendance is limited, but those interested in learning more are encouraged to reach out to the Envol team for additional details.
We look forward to connecting with colleagues, partners, and innovators from across the biotechnology community and discussing how Envol Biomedical can help accelerate the path from discovery to development.